Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study.

Yamazaki S, Takayama T, Nakamura M, Higaki T, Matsuoka S, Mizuno S, Moriyama M.

J Gastroenterol. 2014 May;49(5):917-22. doi: 10.1007/s00535-013-0841-y. Epub 2013 Jun 18.

PMID:
23775207
2.

Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices.

Nakayama H, Masuda H, Miyake H, Takayama T, Yokoyama E.

Digestion. 2004;70(4):233-9. Epub 2004 Dec 21.

PMID:
15627772
3.

Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices.

Harada N, Shirabe K, Maeda T, Kayashima H, Ishida T, Maehara Y.

World J Surg. 2015 Oct;39(10):2510-8. doi: 10.1007/s00268-015-3110-9.

PMID:
26059406
4.

Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma.

Lisotti A, Azzaroli F, Montagnani M, Porro A, Mazzella G.

J Gastroenterol. 2014 May;49(5):954-5. doi: 10.1007/s00535-014-0935-1. Epub 2014 Feb 8. No abstract available.

PMID:
24509609
5.

Reply to correlation between indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma.

Yamazaki S, Takayama T.

J Gastroenterol. 2014 May;49(5):956-7. doi: 10.1007/s00535-014-0937-z. Epub 2014 Feb 11. No abstract available.

PMID:
24510282
6.

Successful surgical treatment for hepatocellular carcinoma and concomitant risky esophageal varices.

Yamamoto S, Sato Y, Takeishi T, Hirano K, Kobayashi T, Watanabe T, Hatakeyama K.

Hepatogastroenterology. 2005 Jul-Aug;52(64):1083-6.

PMID:
16001634
7.

Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma.

Yeh JL, Peng YC, Tung CF, Yang DY, Hu WH, Chow WK, Yeh HZ, Chen GH.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1603-8.

PMID:
14571795
8.

Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial.

Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI, Chiang HT.

J Hepatol. 1999 Sep;31(3):451-6.

PMID:
10488703
9.

High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: assessment with liver computed tomography.

Kim H, Choi D, Lee JH, Lee SJ, Jo H, Gwak GY, Koh KC, Choi MS, Kim S.

World J Gastroenterol. 2012 Sep 21;18(35):4905-11.

10.

Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma.

Akanuma M, Yoshida H, Okamoto M, Ogura K, Maeda S, Hata Y, Sato S, Shiina S, Kawabe T, Shiratori Y, Omata M.

Hepatogastroenterology. 2002 Jul-Aug;49(46):1039-44.

PMID:
12143197
11.

Clinical trial of prophylactic endoscopic variceal ligation for esophageal varices.

Kishimoto H, Sakai M, Kajiyama T, Torii A, Ueda S, Shimada Y, Inoue K, Imamura M, Okuma M.

J Gastroenterol. 1997 Feb;32(1):6-11.

PMID:
9058288
12.

Non-invasive predictors of esophageal varices.

Cherian JV, Deepak N, Ponnusamy RP, Somasundaram A, Jayanthi V.

Saudi J Gastroenterol. 2011 Jan-Feb;17(1):64-8. doi: 10.4103/1319-3767.74470.

13.

Influence of high-risk esophageal varices on outcomes in hepatocellular carcinoma patients: benefits of prophylactic endoscopic therapies.

Tamaoki M, Toshikuni N, Matsueda K, Yamamoto H.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2557-63.

PMID:
22591679
14.

Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma.

Giannini EG, Risso D, Testa R, Trevisani F, Di Nolfo MA, Del Poggio P, Benvegnù L, Ludovico Rapaccini G, Farinati F, Zoli M, Borzio F, Caturelli E; Italian Liver Cancer (ITA.LI.CA.) Group..

Clin Gastroenterol Hepatol. 2006 Nov;4(11):1378-84. Epub 2006 Oct 23.

PMID:
17059899
15.

Low power diode laser treatment using indocyanine green for eradication of esophageal varices.

Hino S, Kakutani H, Ikeda K, Yasue H, Sumiyama K, Uchiyama Y, Kuramochi A, Matsuda K, Arakawa H, Kawamura M, Masuda K, Suzuki H, Hayashi T, Nakamura N, Arai T, Kikuchi M.

Endoscopy. 2001 Oct;33(10):873-5.

PMID:
11571685
16.

Microwave coagulation versus sclerotherapy after band ligation to prevent recurrence of high risk of bleeding esophageal varices in Child-Pugh's A and B patients.

Monici LT, Meirelles-Santos JO, Soares EC, Mesquita MA, Zeitune JM, Montes CG, Almeida JR, Yamanaka A, Magna LA.

J Gastroenterol. 2010 Feb;45(2):204-10. doi: 10.1007/s00535-009-0134-7. Epub 2009 Oct 3.

PMID:
19802519
17.

Endoscopic injection sclerotherapy with ligation versus endoscopic injection sclerotherapy alone in the management of esophageal varices: a prospective randomized trial.

Shigemitsu T, Yoshida T, Harada T, Takeo Y, Nakamura H, Okita K.

Hepatogastroenterology. 2000 May-Jun;47(33):733-7.

PMID:
10919021
18.

[Treatment of hepatocellular carcinoma with esophageal varices].

Futagawa S, Kojima K, Sugiura M.

Nihon Geka Gakkai Zasshi. 1985 Sep;86(9):1234-6. Japanese.

PMID:
3003559
19.

Endoscopic injection sclerotherapy for esophageal varices associated with concomitant portal venous thrombus of hepatocellular carcinoma.

Ohta M, Hashizume M, Tomikawa M, Kamakura T, Akazawa K, Ueno K, Yamaga H, Kitano S, Tanoue K, Matsumata T, et al.

J Surg Oncol. 1995 Jun;59(2):125-30.

PMID:
7776653
20.

Advances in the treatment of hepatocellular carcinoma and concomitant esophageal varices.

Matsumata T, Kanematsu T, Shirabe K, Takenaka K, Kitano S, Sugimachi K.

Hepatogastroenterology. 1990 Oct;37(5):461-4.

PMID:
2174824

Supplemental Content

Support Center